Development of epigenome therapeutics to improve cognitive dysfunctions in schizophrenia.

FUKUDA MAYU; MUKAI JUN

Art

J-GLOBAL ID：202102233210641910 Reference number：21A0282535

Development of epigenome therapeutics to improve cognitive dysfunctions in schizophrenia.

統合失調症治療の最前線統合失調症の認知機能障害を改善するエピゲノム治療薬の開発

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=21A0282535&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0282535&from=J-GLOBAL&jstjournalNo=L5273A") }}

Author (2)： ,
Material：
Volume： 38 Issue： 2 Page： 220-228 Publication year： Feb. 28, 2021
JST Material Number： L5273A ISSN： 1347-4790 Document type： Article
Article type：文献レビュー Country of issue： Japan (JPN) Language： JAPANESE (JA)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0282535&from=J-GLOBAL&jstjournalNo=L5273A") }}

Basic psychiatry , Basic research of enzyme preparations and enzyme inhibitor preparations

, , , , , , ,

, , , , ,

Return to Previous Page